Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/28195
Title: | Dimethyl fumarate treatment in multiple sclerosis: Recent advances in clinical and immunological studies. | Authors: | Hupperts, Raymond FRAUSSEN, Judith MONTES DIAZ, Gwendoline SOMERS, Veerle |
Issue Date: | 2018 | Source: | Autoimmunity reviews, 17(12), p. 1240-1250 | Abstract: | Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system (CNS) in which demyelination and neurodegeneration occurs. The immune system of MS patients is characterized by a dysregulation in the balance between pro- and anti-inflammatory immune cells, whereby both the innate and adaptive immune system are involved. Dimethyl fumarate (DMF) was licensed in 2013 as an oral first-line therapy for relapsing-remitting (RR)MS patients. It has a strong efficacy with neuroprotective and immunomodulatory effects and a favourable benefit-risk profile. However, the effects of DMF on the immune system of MS patients were not clear before entering the market. During the last years, numerous in vitro and ex vivo studies have clarified the working mechanism of DMF in MS. Here, we discuss the pharmacokinetics of DMF and its effect on molecular immune-related pathways, which is further linked to the clinical and immunological effects of DMF treatment. The efficacy and safety of DMF treatment for RRMS is discussed as reported from clinical trials. Further, the immunological effects of DMF treatment in RRMS patients are addressed in more detail, including the distribution and function of immune cells. Taken together, evidence from recent studies points to a multifactorial working mechanism of DMF treatment in MS which leads to a restored immune balance favouring a more tolerogenic or anti-inflammatory immune profile. | Keywords: | Multiple sclerosis; Dimethyl fumarate; Adaptive immune system; Innate immune system; B cells; T cells; Nrf2; NF-κB | Document URI: | http://hdl.handle.net/1942/28195 | ISSN: | 1568-9972 | e-ISSN: | 1873-0183 | DOI: | 10.1016/j.autrev.2018.07.001 | ISI #: | 000452569600010 | Rights: | 2018 Elsevier B.V. All rights reserved. | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2019 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1-s2.0-S1568997218302374-main.pdf Restricted Access | Published version | 1.35 MB | Adobe PDF | View/Open Request a copy |
DMF review final 180629.pdf | Peer-reviewed author version | 841.61 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
20
checked on Sep 5, 2020
WEB OF SCIENCETM
Citations
75
checked on Oct 13, 2024
Page view(s)
130
checked on Sep 7, 2022
Download(s)
792
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.